Form 4/A for BIOA BioAge Labs, Inc.
Accepted 2025-03-10 00:00:00 ET · period of report 2024-04-17 · accession 0001415889-25-007506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-03-10 | 2024-09-27 | BIOA | Hemrajani Rekha | Dir | P - Purchase | $18.00 | +3,000 | 3,000 | New | +$54.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-27 | P | A | 3,000 | $18.00 | 3,000 | D | — | — | (F1) The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering. |